Page last updated: 2024-11-01

ondansetron and Amaurosis

ondansetron has been researched along with Amaurosis in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"Progressive encephalopathy and partial loss of vision were the main observed signs."2.39Subacute encephalopathic toxicity of cisplatin. ( Conrad, CA; Hong, WK; Verschraegen, C, 1995)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perry, JD1
Cherian, A1
Maguire, M1
Verschraegen, C1
Conrad, CA1
Hong, WK1

Reviews

1 review available for ondansetron and Amaurosis

ArticleYear
Subacute encephalopathic toxicity of cisplatin.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Diseases; Ci

1995

Other Studies

2 other studies available for ondansetron and Amaurosis

ArticleYear
Letter to the editor regarding article, "A challenging problem that concerns the aesthetic surgeon".
    Annals of plastic surgery, 2009, Volume: 62, Issue:6

    Topics: Antiemetics; Blindness; Eye Hemorrhage; Humans; Ondansetron; Postoperative Nausea and Vomiting

2009
Transient blindness following intravenous ondansetron.
    Anaesthesia, 2005, Volume: 60, Issue:9

    Topics: Adult; Antiemetics; Blindness; Female; Humans; Ondansetron; Postoperative Complications; Postoperati

2005